Globus Integrates Nevro Amid Ongoing Headwinds Company Revenue The Numbers Excluding contributions from newly-acquired Nevro, Globus grew in the low single digits for the second quarter and first half of 2025. Aug 12, 2025
Stryker Trauma Leader Talks Culture and Innovation Executive Insights Industry Voices We spoke with Eric Tamweber, Stryker’s Vice President and General Manager of Trauma, about the culture and innovation driving its core trauma business. Aug 11, 2025
Zimmer Biomet Sees Optionality as Pathway to Robotics Leadership Company Revenue The Numbers The company grew in the high single digits in the second quarter of 2025, with a significant portion of growth coming from Paragon 28. Aug 11, 2025
Orthopedic Companies Report Results from Second Quarter 2025 Market Analysis The Numbers Stay up to date on the orthopedic market's 2Q performance in 2025 as we update this post with company sales data and industry developments. Aug 11, 2025
Smith+Nephew Turns Corner in Ortho Recovery Company Revenue The Numbers The company grew in the mid-single-digits amid steadily improving performance, operations and new product uptake. Aug 08, 2025
Orthofix Solidifying Unique Position in U.S. Market Company Revenue The Numbers The company grew in the low-single-digits as its completes a distributor transition but had notable wins in trauma and bone growth therapies. Aug 07, 2025
ATEC’s Approach Resonating with Spine Surgeons Company Revenue The Numbers The company continued its market-leading growth as it seeks to meaningfully reduce the complexity and variability of spine surgery. Aug 06, 2025
Vericel’s MACI Arthro Paves Way for Future Growth Company Revenue The Numbers MACI continued its impressive growth with strong business fundamentals, while MACI Arthro is gearing up to be a major growth driver. Aug 06, 2025
Stryker Remains Strong in Fastest-Growing Segments Company Revenue The Numbers Excluding its divested spinal implant business, Stryker's orthopedic sales grew double-digits in the second quarter of 2025. Aug 04, 2025
CONMED Banking on Innovation to Stem Share Losses Company Revenue The Numbers The company's orthopedic business remains challenged by supply chain troubles, but BioBrace and foot and ankle have been bright spots. Aug 01, 2025